Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
Go back to Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control| (NASDAQ: CRNX) | Delayed: 84.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.95 | 52 Week High | $ | |||
| Open | $84.95 | 52 Week Low | $ | |||
| Day High | $84.95 | P/E | N/A | |||
| Day Low | $84.95 | EPS | $ | |||
| Volume | 910,230 | |||||

